KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Elevance Health (ELV) Asset Writedowns and Impairment (2016 - 2025)

Historic Asset Writedowns and Impairment for Elevance Health (ELV) over the last 15 years, with Q4 2025 value amounting to $38.0 million.

  • Elevance Health's Asset Writedowns and Impairment changed N/A to $38.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $45.0 million, marking a year-over-year decrease of 4375.0%. This contributed to the annual value of $108.0 million for FY2025, which is 485.44% up from last year.
  • Latest data reveals that Elevance Health reported Asset Writedowns and Impairment of $38.0 million as of Q4 2025.
  • In the past 5 years, Elevance Health's Asset Writedowns and Impairment registered a high of $73.0 million during Q4 2021, and its lowest value of $7.0 million during Q4 2022.
  • In the last 3 years, Elevance Health's Asset Writedowns and Impairment had a median value of $38.0 million in 2025 and averaged $39.3 million.
  • In the last 5 years, Elevance Health's Asset Writedowns and Impairment soared by 233333.33% in 2021 and then crashed by 9041.1% in 2022.
  • Over the past 3 years, Elevance Health's Asset Writedowns and Impairment (Quarter) stood at $73.0 million in 2021, then crashed by 90.41% to $7.0 million in 2022, then surged by 442.86% to $38.0 million in 2025.
  • Its Asset Writedowns and Impairment stands at $38.0 million for Q4 2025, versus $7.0 million for Q4 2022 and $73.0 million for Q4 2021.